Abbott plans to separate its nutrition business into an independent company, which is set to house electrolyte-beverage brand Pedialyte, as well as infant-formula brand Similac, with about $8.5 billion in annual sales.
Abbott plans to separate its nutrition business into an independent company, which is set to house electrolyte-beverage brand Pedialyte, as well as infant-formula brand Similac, with about $8.5 billion in annual sales.